Tafenoquine Thorough QTc Study in Healthy Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2011
This will be a randomized, single-blind, placebo controlled, parallel group study. Approximately 260 subjects will be enrolled in five groups. This study is designed to compare the effects of tafenoquine, administered as single dose as well as administered over three consecutive days, on the changes in QT duration to those observed in subjects dosed with either moxifloxacin or placebo.
Epistemonikos ID: c9c18d3863436d100b9ce9d1bbdcf685f861fceb
First added on: May 11, 2024